Titan Medical Inc.

Symbol: TMDI




Market price today

  • -0.5117

    P/E Ratio

  • -0.0085

    PEG Ratio

  • 15.66M

    MRK Cap

  • 0.00%

    DIV Yield

Titan Medical Inc. (TMDI) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical Devices
CEO:Mr. Cary G. Vance
Full-time employees:49
Address:76 Berkeley Street

Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.

General Outlook

In simple terms, Titan Medical Inc. has 111.891 M shares that people are buying and selling right now.

Return on Investments

The company's asset efficiency, represented by a robust -1.691% return, is a testament to Titan Medical Inc.'s adeptness in optimizing resource deployment. Titan Medical Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -1.844%. Furthermore, the proficiency of Titan Medical Inc. in capital utilization is underscored by a remarkable -3.720% return on capital employed.

Stock Prices

Titan Medical Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.2254, while its low point bottomed out at $0.2041. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Titan Medical Inc.'s stock market.

Liquidity Ratios

Analyzing TMDI liquidity ratios reveals its financial health of the firm. The current ratio of 141.44% gauges short-term asset coverage for liabilities. The quick ratio (117.54%) assesses immediate liquidity, while the cash ratio (117.54%) indicates cash reserves.

Current Ratio141.44%
Quick Ratio117.54%
Cash Ratio117.54%

Profitability Ratios

The effective tax rate stands at -0.25%, revealing its tax efficiency. The net income per EBT, 100.25%, and the EBT per EBIT, 100.25%, provide insights into its earnings hierarchy.

Effective Tax Rate-0.25%
Net Income per EBT100.25%
EBT per EBIT100.25%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.41, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

Days of Sales Outstanding118

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.18, and free cash flow per share, -0.18, depict cash generation on a per-share basis. The cash per share value, 0.10, showcases liquidity position.

Operating Cash Flow per Share-0.18
Free Cash Flow per Share-0.18
Cash per Share0.10
Free Cash Flow to Operating Cash Flow Ratio1.03
Cash Flow Coverage Ratio-13.29
Short Term Coverage Ratio-61.49
Capital Expenditure Coverage Ratio-28.60
Dividend Paid and Capex Coverage Ratio-28.60

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 8.19%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.21, we discern the balance between debt and equity financing. The long-term debt to capitalization, 14.29%, and total debt to capitalization, 17.55%, ratios shed light on its capital structure. An interest coverage of -394.77 indicates its ability to manage interest expenses.

Debt Ratio8.19%
Debt Equity Ratio0.21
Long Term Debt to Capitalization14.29%
Total Debt to Capitalization17.55%
Interest Coverage-394.77
Cash Flow to Debt Ratio-13.29
Company Equity Multiplier2.60

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.30, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.22, reflects the portion of profit attributed to each share. The book value per share, 0.53, represents the net asset value distributed per share, while the tangible book value per share, 0.50, excludes intangible assets.

Revenue Per Share0.30
Net Income Per Share-0.22
Book Value Per Share0.53
Tangible Book Value Per Share0.50
Shareholders Equity Per Share0.53
Interest Debt Per Share0.02
Capex Per Share-0.01

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 10,908,261.515, captures the company's total value, considering both debt and equity. Income quality, 2.46, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.62, gauges operational efficiency, while the research and development to revenue, 188.90%, highlights investment in innovation. The ratio of intangibles to total assets, 4.06%, indicates the value of non-physical assets, and capex to operating cash flow, 2.06%, measures reinvestment capability.

Enterprise Value10,908,261.515
Income Quality2.46
Sales General and Administrative to Revenue0.62
Research and Development to Revenue188.90%
Intangibles to Total Assets4.06%
Capex to Operating Cash Flow2.06%
Capex to Revenue-3.76%
Capex to Depreciation-108.01%
Stock-Based Compensation to Revenue20.09%
Graham Number1.62
Return on Tangible Assets-32.80%
Graham Net Net0.40
Working Capital32,770,000
Tangible Asset Value33,374,000
Net Current Asset Value31,733,000
Average Receivables4,175,783
Days Sales Outstanding150

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.25, and the price to book ratio, 2.25, reflect the market's valuation relative to the company's book value. Ratios like price to free cash flows, -0.77, and price to operating cash flows, -0.79, gauge market valuation against cash flow metrics.

Price Book Value Ratio2.25
Price to Book Ratio2.25
Price Cash Flow Ratio-0.79
Price Earnings to Growth Ratio-0.01
Enterprise Value Multiple-0.87
Price Fair Value2.25
Price to Operating Cash Flow Ratio-0.79
Price to Free Cash Flows Ratio-0.77
Price to Tangible Book Ratio1.19
Enterprise Value to Sales0.54
Enterprise Value Over EBITDA-0.78
EV to Operating Cash Flow-0.30
Earnings Yield-35.47%
Free Cash Flow Yield-89.22%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Titan Medical Inc. (TMDI) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.512 in 2024.

What is the ticker symbol of Titan Medical Inc. stock?

The ticker symbol of Titan Medical Inc. stock is TMDI.

What is company IPO date?

IPO date of Titan Medical Inc. is 2008-04-28.

What is company current share price?

Current share price is 0.140 USD.

What is stock market cap today?

The market cap of stock today is 15664740.000.

What is PEG ratio in 2024?

The current -0.009 is -0.009 in 2024.

What is the number of employees in 2024?

In 2024 the company has 49.